StonvexLoading…
StonvexStonvexStonvexCore line items from BL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $183.16M | $700.43M | $517.25M | $338.96M |
Operating Income | $6.24M | $25.55M | $18.73M | $11.12M |
Net Income | $8.13M | $24.52M | $19.63M | $14.35M |
EPS (Diluted) | $0.13 | $0.39 | $0.31 | $0.23 |
Total Assets | $1.46B | $1.76B | $1.70B | $1.79B |
Total Liabilities | $1.12B | $1.39B | $1.34B | $1.34B |
Cash & Equivalents | $242.04M | $390.03M | $419.90M | $459.14M |
Free Cash Flow OCF − CapEx | $44.18M | $161.49M | $135.44M | $72.17M |
Shares Outstanding | 59.17M | 59.88M | 59.94M | 61.88M |